Novavax COVID-19 Vaccine Could Get EU Approval ‘In Weeks’

Having completed a rolling review, the vaccine is now being evaluated by the European Medicines Agency for conditional marketing authorization under an accelerated timeline.

Inspection and control of vaccines on the production line
Another COVID-19 vaccine could soon be on the way • Source: Alamy

The EU could see its fifth COVID-19 vaccine approved in a matter of weeks after the European Medicines Agency said it had begun reviewing Novavax, Inc.’s application for a conditional marketing authorization (CMA) for Nuvaxovid (also known as NVX-CoV2373).

The EMA said the evaluation would be carried out under an accelerated timeline because it had already assessed a substantial proportion of the data during the rolling review stage, which...

More from Europe

More from Geography